Company:  ATRICURE, INC. (ATRC)
Form Type:  4
Filing Date:  2/16/2012 
CIK:  0001323885 
Address:  7555 INNOVATION WAY 
City, State, Zip:  MASON, Ohio 45040 
Telephone:  513-755-4100 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$16.53  
Change: 
0.19 (1.16%)  
Trade Time: 
Feb 12  
Market Cap: 
$532.54M
Trade ATRC now with 

© 2016  
Description of Business
We are a medical device company providing innovative atrial fibrillation (Afib) solutions designed to produce superior outcomes that reduce the economic and social burden of atrial fibrillation. We have two primary product lines for the ablation of cardiac tissue. Our Isolator Synergy® Ablation System is the first and only surgical device approved by the United States Food and Drug Administration (FDA) for the treatment of Afib. Our cryoICE(TM) cryosurgery product line offers a variety of both single use and reusable cryoablation devices. Our AtriClip® Left Atrial Appendage Exclusion System is the most widely sold device worldwide specifically designed to occlude the heart's left atrial appendage (LAA). We believe cardiothoracic surgeons are adopting our ablation and LAA management (LAAM) devices to cure Afib and reduce Afib-related complications such as stroke.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES